Buprenorphine Treatment for Young Adults

Buprenorphine Treatment for Young Adults

Responsive image
The Buprenorphine Treatment for Young Adults Blending Team designed a training package which highlights the findings of the NIDA CTN study that compared longer term versus short-term buprenorphine/naloxone treatment in an outpatient setting. The 3-hour training program examines the prevalence of and treatment admission rates for nonmedical use of opioids among young adults; provides an overview of opioid use among young adults; explores and increases understanding of the results of new research on using buprenorphine to treat opioid addiction in young adults; and describes the implications of these findings for the treatment of opioid addiction in young adults.

 

Buprenorphine For Young Adults Blending Team Members

NIDA/ NDAT CTN

  • Laura F. McNicholas, M.D., Ph.D. - Philadelphia VAMC
  • Michael P. Bogenschutz, M.D. - The University of New Mexico
  • Geetha Subramanian, M.D. - Johns Hopkins University
  • Shannon Garrett, M.S.W., LGSW - Mountain Manor Treatment Center
  • Susan Storti, Ph.D., R.N., CARN-AP - Synergy Enterprises, Inc.
  • NIDA CTN Lead Investigator: George Woody, M.D., University of Pennsylvania

SAMHSA/CSAT-ATTC

  • Thomas Freese, Ph.D. - Pacific Southwest ATTC (Chair)
  • Pamela Waters, M.Ed. - Southern Coast ATTC
  • Thomas Durham, Ph.D., LDAC - Central East ATTC
  • Beth Rutkowski, M.P.H. - Pacific Southwest ATTC

SAMHSA/CSAT Buprenorphine Information Center

Visit Site

This is the site of SAMHSA/CSAT's Buprenorphine Information Center. Included in the site are: general information (e.g., buprenorphine, DATA 2000, Physician and Treatment Program Locator), links to buprenorphine-related reports and publications, and a section specifically for physicians.

Statistics

  • In 2007, there were 7,000 new initiates of nonmedical use of opioids daily.
  • Among youth ages 12-17, females are more likely to use opioids nonmedically.
  • Among young adults ages 18-25, males are more likely to use opioids nonmedically.
  • The Monitoring the Future survey showed that nearly 10% of 12th graders reported past year nonmedical use of Vicodin, and 4.7% reported OxyContin use in 2008.

Articles

Extended vs. short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial, Woody et al. JAMA article